Simulations Plus, Inc. (SLP)
NASDAQ • Technology
Last close at October 7, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Simulations Plus, Inc. keeps $16 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Simulations Plus beat expectations on both the top and bottom line in the third fiscal quarter of 2026, reported July 9, 2026, as adjusted EPS of $0.30 topped the $0.23 estimate (+29%) and revenue of $21.9 million topped the $20.9 million estimate (+4.7%). Revenue rose 7.5% to about $21.9 million from roughly $20.4 million a year ago, with the Americas—its largest region—up ~10% to about $16.1 million, while EMEA slipped ~3% to roughly $3.6 million and Asia Pacific increased ~6% to about $2.2 million. Gross profit came in around $15.1 million, with gross margin at roughly 69.1%, and the quarter generated operating cash flow of about $10.2 million. For the next period, consensus calls for EPS of $0.11 on revenue of $17.6 million.
Next report — what to expect
Simulations Plus, Inc. (SLP) reports on October 29, 2026. Wall Street is looking for EPS of $0.09 on revenue of $17.4 million. For trailing context, revenue grew +7.5% year over year last quarter. SLP has beaten EPS in 4 of its 8 most recent quarters.
About Simulations Plus, Inc.
Simulations Plus, Inc. (NASDAQ: SLP) develops scientific software for drug and molecular modeling, serving the life-sciences and regulated-product markets as an application software company. In FY2025, revenue was $79.2 million. Its platform combines simulation, quantitative pharmacology, and predictive chemistry tools used across research, development, and regulatory work.
Today's Snapshot
Yesterday SLP finished level at 18.50.
vs S&P 500 Today
Underperforming Market
-0.70%
Updated: October 27, 2026 at 12:07 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$16.95 - $18.48Buy
- RSI (14)65.06Neutral
- Stochastic %K (14, 3, 3)100.00Sell
- MACD Level (12, 26)0.03Buy
Peers & Related Assets
Get premium market insights delivered directly to your inbox.